Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiCM-188 in severe chronic heart failure
NCT03763136Phase 2Completed
- Sponsor
- Help Therapeutics
- Start
- Oct 2021
- Primary completion
- Apr 2024
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of HiCM-188 in chronic heart failure (CHF), sponsored by Help Therapeutics. Started Oct 2021; status: completed.
02
Drugs
HiCM-188
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT03763136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763136.